Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy

To compare the response to different insulin regimens for management of hyperglycemia in diabetic patients with hematologic malignancies who are receiving dexamethasone. A retrospective analysis was conducted to determine whether a basal bolus insulin (BBI) regimen with detemir and aspart is superio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine practice 2013-03, Vol.19 (2), p.231-235
Hauptverfasser:	Gosmanov, Aidar R, Goorha, Salil, Stelts, Sundae, Peng, Limin, Umpierrez, Guillermo E
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents, Hormonal - adverse effects Antineoplastic Agents, Hormonal - therapeutic use Body Mass Index Dexamethasone - adverse effects Dexamethasone - therapeutic use Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Drug Administration Schedule Drug Monitoring Female Glucocorticoids - adverse effects Glucocorticoids - therapeutic use Hematologic Neoplasms - blood Hematologic Neoplasms - complications Hematologic Neoplasms - drug therapy Humans Hyperglycemia - chemically induced Hyperglycemia - prevention & control Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Insulin - administration & dosage Insulin - therapeutic use Insulin Aspart - administration & dosage Insulin Aspart - therapeutic use Insulin Detemir Insulin, Long-Acting - administration & dosage Insulin, Long-Acting - therapeutic use Insulin, Regular, Human - administration & dosage Insulin, Regular, Human - therapeutic use Male Middle Aged Obesity - complications Pilot Projects Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!